Qlarity Imaging, a leading innovator in artificial intelligence (AI) diagnostics and portfolio company of Paragon Biosciences, and Blackford, the provider of the dedicated platform for medical imaging applications and AI, today announced their agreement to integrate QuantX™ within Blackford’s curated marketplace. The partnership will combine the implementation and maintenance gains of a platform-based approach with the increased accuracy and improved reader performance benefits of QuantX™ for breast MRI interpretation to help deliver better outcomes for more radiologists, health systems, and most importantly patients. The integration will feature the new cloud-based, vendor neutral format of QuantX™, which is currently in development and pending application seeking FDA clearance.
Qlarity Imaging and Blackford Partner to Bring QuantX™ Diagnostic AI to More Breast Radiologists via Blackford Platform™, Helping More Patients in Need
